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Abstract
Background:
In cervical cytology, the unsatisfactory rates for ThinPrep (TP) are slightly higher compared to SurePath.
We examined various causes and explored potential for resolution of this discrepancy.
Materials and Methods:
Totally, 19,422 cases were reviewed and 1000 unsatisfactory specimens were selected and analyzed. 531
specimens were available for wash protocol. Out of 114 unsatisfactory specimens associated with atrophic
cellular changes (ACC), 48 were resubmitted by provider and reevaluated.
Results:
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Lubricant and lubricant-like debris/contamination (LUBE) was the most common cause of unsatisfactory
specimens (68%; 681/1000) followed by blood (7.5%); ACC only (without other interfering factors) (2.4%);
inflammation (3.0%); and combinations thereof (1.9%). 11.5% showed scant cellularity without an
identifiable cause. 3.3% were virtually acellular. Wash protocol improved cellularity in 48% (256/531) of
cases. However, only 29% (73/256) of those were satisfactory (with more than 5000 cells). Quantitative
reduction in LUBE after wash protocol varied with different morphological subtypes. Interpretation patterns
on satisfactory specimens after wash protocol were comparable to the results on selected cohort of
specimens during the same study period. Out of 114 ACC, wash protocol was performed on 68 ACC
specimens leading to satisfactory TP in 24% (16/68). Totally, 48 cases reported as unsatisfactory with ACC,
were resubmitted by the providers between 2 weeks and 2 years. 44 (92%) showed increased cellularity, out
of which 52% (23/44) did not show ACC.
Conclusion:
LUBE was the most common cause of unsatisfactory TP in addition to interference by blood and association
with atrophic changes. Knowing the morphological spectrum of LUBE would help to identify it as the cause
of unsatisfactory TP. Communicating the cause of unsatisfactory TP such as LUBE, ACC, and blood would
hint the provider to take appropriate precaution during submission of the repeat specimen, leading to
improved patient care.
Keywords: Cervical cancer, cytology, liquid based cytology, lubricant, Papanicolaou smear, ThinPrep,
wash protocol, unsatisfactory
INTRODUCTION
ThinPrep  (Hologic Inc., Bedford, MA) is one of the liquid based cytology (LBC) methods of Papanicolaou
(Pap) testing for early detection of cervical cancer and its precursor lesions. For a conventional Pap test, the
collected cervical cytology specimen is directly smeared on a glass slide, wet-fixed in 95% ethanol, and then
stained with Pap stain for cytomorphologic evaluation. In contrast, the ThinPrep  Pap (TP) test sample is
collected and placed in a weak fixative medium in a collection vial and sent to a cytopathology laboratory
for further processing. A few clinical advantages of LBC include prevention of air-drying artifact (which is
not uncommon with conventional smears) and preservation of the residual specimen (for ancillary reflex
tests such as human papillomavirus [HPV] testing) without the inconvenience (for the patient and the
clinician) of collecting a new specimen.
Unsatisfactory rates for TP are lower than conventional Pap smears (1–5.9%); however, rates are relatively
higher (1.1–3.4%) compared to other LBC method such as SurePath (0.3–1.3%).[1,2,3,4,5,6] In this
prospective study, we examined various causes of unsatisfactory TP specimens. In our tertiary care
university hospital, we have a significant community outreach component and experience periodic surges in
the unsatisfactory rates. We also evaluated possible approaches to overcome these factors and improve the
unsatisfactory rate.[1,2,3]
MATERIALS AND METHODS
We analyzed 19,422 TP specimens from women 12 through 86 years of age (with the mean age of 51 years)
over a 5½ months period after IRB approval. By strict adherence to the “2001 Bethesda System” criteria,
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1000 TP were deemed inadequate for interpretation. This yields relatively higher unsatisfactory rate of
5.1%.[7] The cases were analyzed to identify the potential causes of the unsatisfactory interpretations [
Figure 1] and assessed for the amount of residual specimen. Of these 1000, there were enough residual TP
specimens in 531 cases. A variety of factors such as utilization of specimen for reflex HPV testing,
processing for repeat preparation, or other logistics were responsible for the nonavailability of residual TP
specimen in 469 cases. These 531 specimens (which included 381 with debris such as lubricant and
lubricant-like debris/contamination (LUBE) [Figure 2] and 150 others) were reprocessed with wash protocol
mentioned below.[8]
All specimens were anonymized and after wash protocol (see below) [Figure 3], all repeat TP were
examined by two cytotechnologists with final review by two or more cytopathologists. The cellularity and
amount of residual LUBE were evaluated.
Out of 114 specimens initially reported as unsatisfactory with scant cellularity in association with atrophic
cellular changes (ACC) including atrophic vaginitis (mostly reported with a note to repeat after topical or
systemic estrogen therapy to reverse ACC), 48 were repeated by resubmitting new specimens within a time
period ranging from 2 weeks to 2 years (average of 5 months). These resubmitted TP specimens were also
analyzed.
Multiple wash protocols were evaluated to test efficiency in overcoming interference related to LUBE. The
simplest protocol achieving the best outcome (increased cellularity of the repeated TP) was finalized.[8]
This simple protocol [Figure 3] is as follows:
Protocol [Figure 3]
Pour specimen in centrifuge tube and spin at about 2250 G force/relative centrifugal force (G)
(1000 revolutions per minute on centrifuge with a radius of rotation 19 cm) for 5 min.[9] (If the
amount of specimen is <20 ml, add PreservCyt  to make it to 20 ml, mix, and centrifuge)
Discard the supernatant
Add PreservCyt  to make it to 20 ml, mix, and centrifuge at about 2250 G for 5 min
Discard the supernatant
Repeat the previous step (add 20 ml PreservCyt , mix and centrifuge at about 2250 G for 5 min)
one more time
Discard the supernatant and reconstitute specimen with PreservCyt  to make it to 20 ml
Run it on TP machine to prepare the smear and stain with Pap stain
Save the residual in the TP vial for elective tests including reflex HPV testing as indicated.
(For a brief video demonstration see https://www.youtube.com/watch?v = nFvqz9BGfXc).[8]
RESULTS
LUBE related scant cellularity was the most common cause (68%; 681 out of 1000) of unsatisfactory
interpretations. The remaining 32% of causes were: Blood (7.5%), ACC (2.4%), inflammation (3.0%),
mucin (1.3%), clumping without other cause (0.6%), thick smear (0.4%), and combination of any of these
causes (1.9%). Thirty-three (3.3%) specimens were virtually acellular. 11.4% of specimens showed scant
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collection) [Figure 1 and Table 1].
LUBE demonstrated various morphological patterns in Pap stained TP [Figure 2 and Table 2]. Poorly
staining refractile granular LUBE was the most common variant with or without other associated causes
noted in 39% (264/681), but this variant was relatively difficult to identify due to the morphological overlap
with erythrocyte stroma (lysed red blood cells). Mucin-like and wispy mucin-like LUBE were difficult to
distinguish from regular mucin. Some LUBEs were also associated with a tendency to cell clumping with
thick cell groups, thus interfering with cytomorphological evaluation.
Repeat TP and staining after wash protocol showed increased cellularity in 48% (256 out of 531) of the
specimens [Figure 4]. In specimens with blood and LUBE together, the cellularity improved in relatively
fewer cases [31%, 26 out of 84; Figure 5]. Out of 256 with improved cellularity, 29% (73 out of 256) were
satisfactory (over 5000 cells per TP) with good cellularity in 22% (56 out of 256) and satisfactory but with
borderline cellularity (just over 5000 cells per TP) in 7% [17 out of 256; Figure 6]. The overall satisfactory
rate achieved in these specimens with LUBE after the wash protocol was 13.7% (73 out of 531). Thus, for
effective reduction in the unsatisfactory rate, the preferred approach should be to avoid contamination with
LUBE at specimen collection stage itself.
The proportion of LUBE in the background decreased variably with different morphological subtypes of
LUBE (78% [62/80] for dendritic-fluffy type [Figure 4], 80% [16/20] for flake-like, 70% [14/20] for wispy
mucin-like, 100% [14/14] for transparent dirt-trapping membranes).
Cytologic interpretation on repeat TP (after wash protocol in the specimens which became satisfactory)
showed 89% negative for intraepithelial lesion or malignancy, 8% atypical squamous cells of undetermined
significance, 1% low-grade squamous intraepithelial lesion (LSIL), 1% atypical squamous cells – cannot
exclude a high-grade squamous intraepithelial lesion (ASC-H), and 1% atypical glandular cells (AGC) [
Table 3]. Although relatively small in number, the interpretation pattern was compared with routine results
on satisfactory TP in the same population (selected randomly from three random days corresponding with
the study period). Although AGC and HSIL together were comparable, LSIL rate was relatively lower for
specimens undergoing wash protocol [1% as compared to 5% in the general pool; Table 3].
ACC with scant squamous cellularity was noted in 11.4% (114 out of 1000) specimens. This category
showed higher frequency (73.7%; 84/114) of association with LUBE contamination (these cases were
signed-out with recommendation to repeat after local or systemic estrogen therapy without contamination
with LUBE) as compared to (26.3%; 30/114) ACC specimens without LUBE (these cases were signed-out
with recommendation to repeat after local or systemic estrogen therapy). Out of 114 ACC specimens, the
wash protocol could be applied to 68 specimens. Nineteen (27.9%) specimens showed improved cellularity
(19/68). Out of these 19 cases, a total of 16 became satisfactory: 11% (2/19) were borderline satisfactory
and 74% (14/19) were satisfactory with good cellularity.
Forty-eight (with and without LUBE contamination) specimens previously with ACC and reported as
unsatisfactory were repeated (within 2 weeks - 2 years) and showed increased cellularity in 44 (ACC was
still observed in 48%, 21/44). The proportion of specimens in repeated cases with previous atrophic
changes, LUBE decreased to 30% in the resubmitted cohort.
Sixteen out of 30 initially unsatisfactory specimens with ACC but without LUBE were repeated as a new
specimen collected at later date and showed a reduction in the unsatisfactory rate to 6.3% (1/16), the
remaining 14 cases could not be followed as repeated specimen.
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Thirty-two out of 84 unsatisfactory ACC specimens with LUBE contamination were repeated as a new
collection at a later date with relatively reduced unsatisfactory rate to 9% (3/32). Fifty two cases could not
be confirmed whether TP was repeated without LUBE.
DISCUSSION
The Pap test has been highly effective in decreasing the prevalence of advanced cervical cancer and related
morbidity/mortality in the western world.[10,11] Recently, there have been a variety of enhancements made
to the Pap test as regards the reproducible quality of cytology preparations for final cytologic interpretation.
There have been many other ongoing enhancements including standardized Bethesda nomenclature,[12 13]
publications communicating further refinements such as morphological spectrum of ASC-H,[14] LSIL-H as
new category,[15] ancillary role of immunomarkers such as HPV testing and p16.[16,17] All of these
factors have taken the humble test induced initially by Georgios Nikolaou Papanicolau to the highly evolved
test currently in use today. Further refinements in processing by methodologies such as by LBC: TP
(Hologic, Inc., Bedford, MA)[18] and SurePrep  (Becton, Dickinson and Company, Franklin Lakes, NJ)
[19] have added more benefits to this test. However, one of the limiting factors with TP is scant cellularity
due to a variety of technical causes leading to relatively higher unsatisfactory rate.[1,4,5,20,21,22,23]
In brief, the TP sample processing begins with a collection of the cervical specimen in PreservCyt  vials.
An adequate number of squamous epithelial cells including the cells from transformation zone must be
collected and transferred in adequate numbers to the glass slide for satisfactory cytomorphologic evaluation.
The fundamental measure of adequacy being number of squamous cells (more than 5000 nucleated
squamous cells). The TP machine collects the cells on the surface of a filter membrane with small pores
sufficient to aspirate PreservCyt  in the vial while trapping the diagnostic cells on its surface.
The TP machine effects this collection by suction through the pores in the filter membrane. The suction
stops when the holes are blocked by material collected on the filter membrane irrespective of the nature of
the material collected including the diagnostic cells. Any debris such as blood, inflammatory cells, and
contaminants capable of blocking the holes including LUBE can and will prevent the collection of enough
epithelial cells onto the filter membrane.
As reported previously, LUBE was the most frequent factor resulting in decreased cellularity in the final TP
slides.[1] The possibility of compromising of additional testing modalities such as HPV testing due to the
paucity of cells (including cases with atrophic change) and abundance of LUBE in TP vial also exist. Other
studies also have reported similar observations.[6,24,25] Additional significant etiologic factors associated
with high unsatisfactory rate were association with atrophic changes and blood.
In this study over a 5½ months period, a total of 19,422 TP specimens were processed with an
unsatisfactory rate of 5.1%. The higher unsatisfactory rate may be related to variety of etiologic factors
including variation in collection methodologies (preference for the use or avoidance of LUBE), the nature of
the patient population such as preponderance of elderly postmenopausal women (prone to atrophic smear),
sampling skills, etc. The most common cause in this study was an association with LUBE (68%, 681 out of
1000). Only a few cases (3.3%, 33 out of 1000) were virtually acellular. Remaining 28.6% unsatisfactory
specimens were associated with blood, atrophic changes, inflammation, and their combinations. A few
showed scant cellularity without any associated identifiable factor (suggestive of insufficient sampling
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material in TP fixative (PreservCyt ) for a while, and then swirling the brush to loosen and disperse the
cells in PreservCyt . This may fix the specimen on brush as a thin film which would be dislodged as
fragments/clumps while swirling to disperse the specimen. These fragments may block the pores in TP
membrane and interfere with adequate cellularity in final TP.
The practical aspect of identifying various microscopic morphological patterns of LUBE in Pap stained TPs
[Figure 2 and Table 2] would be the recognition of LUBE as a possible reason for inadequate Pap test result
as well as an appropriate communication in final report to prevent trend of repeated unsatisfactory results on
future sample submissions. As a general observation, LUBE was better detected at the periphery (rim of) of
the TP circle. The most common morphological variety was poorly staining refractile granular LUBE
[Tables 1 and 2]. However, this variant was relatively difficult to interpret due to morphological overlap
with erythrocyte stroma. Mucin-like and wispy mucin-like LUBE were difficult to distinguish from regular
mucin [Figure 2]. Rare LUBE was associated with a tendency to cell clumping with increased thickness of
cell groups. This group improved with repeat wash protocol but with suboptimal morphological details.
Acid wash leads to increased tendency for cell clumping when performed on the specimen contaminated
with LUBE. Some studies have reported improved cellularity when a repeat TP was prepared on residual
specimens (without any wash or processing) but with lower success rate, especially if the specimens had
LUBE contaminant.[6]
The optimal approach to prevent LUBE interference challenge would be to avoid contamination with any
debris (including those associated with lubricant used clinically for vaginal examination and for negotiating
the speculum, personal use of lubricant, use of topical medication, postcoital seminal fluid contamination,
etc.,) which may potentially block the pores in the TP filter membrane. Proper collection of cervical
cytology specimens by avoiding contamination with LUBE and blood should be the preferred
recommendation. Additional insurance is instructions to the patients seeking cervical cytology specimens
for Pap test, to avoid topical use of any LUBE like products prior to the collection of sample and other
possible interfering factors including postcoital seminal fluid debris. This approach would avoid
contamination by interfering debris potentially blocking the TP filter membrane pores and thereby
improving cellularity of final TP and consequently lower unsatisfactory rate [Table 4].
Other important factor is to identify LUBE with its garden variety of morphologic patterns in TP [Figure 2]
and to communicate the interference due to LUBE in the report as a feedback with a note “to repeat the
adequately cellular sample without LUBE contamination as clinically indicated.”
The wash protocol used in this study was standardized after evaluating a few combinations of a variety of
steps and reagents including potential incorporation of weak surfactants. The final protocol reported in this
study is the simplest one with minimal steps achieving the best results to improve the cellularity [Figure 3].
[1,8] The improvement in the cellularity was noted not only in specimens with lubricant [Figure 4], but also
in some specimens with other debris or without an identifiable cause. However, this improvement only
achieved a satisfactory rate of 11% (56 out of 531) in processed specimen.
Although relatively small in number, the interpretation pattern was comparable to that with routine results
on satisfactory TP (except for LSIL) in same population during the study period [Table 3]. LSIL rate was
relatively lower for specimens undergoing wash protocol (1% as compared to 5% in general pool). The
significance of this observation should be explored further.
The improved cellularity after wash protocol varied with morphological type of LUBE noted in the initial
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hypocellular TP [Figure 4] (78% [62/80] for dendritic-fluffy type, 80% [16/20] for flake-like, 70% [14/20]
for wispy mucin-like, 100% [14/14] for transparent dirt-trapping membranes).
As compared to the specimens only with LUBE (297 specimens), the wash protocol was less effective for
the specimens with presence of blood with (84 specimens) or without LUBE (89 specimens) [Figure 5].
Cellularity of the specimens with blood and LUBE improved in relatively fewer cases (31%; 26 out of 84)
as compared to 56% in specimens only with LUBE without blood [Figure 5]. Specimens with LUBE
processed after acid wash protocol showed a higher tendency for cell clumping with increased thickness.
Association of LUBE in 114 specimens with ACC was slightly higher (73.7%; 84/114) as compared to
general population (68%; 681/1000). This may be due to the technical benefit of LUBE for negotiating the
speculum in these cases. Most of these cases were signed-out initially with a note to repeat after topical or
systemic estrogen therapy to reverse ACC and avoiding LUBE contamination.
The wash protocol could be applied to 68 ACC specimens (out of 114 cases) with improved cellularity in 19
(28%). Out of these 19 cases, total of 16 showed improved cellularity: Satisfactory with good cellularity in
21% (14/68) and borderline satisfactory in 3% (2/68).
Sixteen out of 30 previously unsatisfactory specimens with ACC (without LUBE contamination) repeated as
a new collection at later date showed relatively reduced unsatisfactory rate of 6.3% (1/16). Thirty-two out of
84 previously unsatisfactory specimens with ACC (with LUBE contamination) repeated as a new collection
at later date showed relatively reduced unsatisfactory rate to 9% (3/32). This improvement may be due to
the feedback related to ACC and LUBE in the report on previously unsatisfactory specimen.
The repeat TP after wash protocol with adequate cellularity showed cytologic interpretation pattern
comparable with the routine results on satisfactory TP in same population during same time period.
However, LSIL rate observed after wash protocol on this small cohort was relatively lower [Table 3].
In summary, LUBE was one of the most common identifiable factors for unsatisfactory TP, with blood
contamination and association with atrophic changes as additional causes [Figure 2; Tables 1 and 2].
Although the best option is to avoid contamination with LUBE during specimen collection, wash protocol
may overcome LUBE interference [Table 4]. The interpretation results of TP after wash protocol showed
patterns comparable to the interpretation patterns on specimens processed as routine TP [Table 3]. In
addition, knowing morphologic patterns of LUBE helps to recognize it in the TP and instead of just
reporting the specimen as “unsatisfactory,” it is recommended to add an educational note/recommendation
to the provider about LUBE interference in the final report with a note “to repeat the adequately cellular
cervical specimen without LUBE contamination as clinically indicated.” This is also applicable to blood
contamination. Similarly for “Unsatisfactory” ACC specimens, a recommendation to “repeat after topical or
systemic estrogen therapy as clinically indicated” may decrease the unsatisfactory rate in the repeated
specimens in this subset with ACC. Possible solutions to overcome these three common factors leading to
unsatisfactory TP are summarized in Table 5.
COMPETING INTERESTS
No competing interest to declare by any of the authors.
Etiologic factors related to unsatisfactory ThinPrep® cervical cytology: Evaluation and potential solutions to improve
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4593297/?report=printable[10/7/2016 9:46:37 AM]
AUTHORSHIP STATEMENT BY ALL AUTHORS
All authors declare that we qualify for authorship as defined by ICMJE http://www.icmje.org/#author
ETHICS STATEMENT BY ALL AUTHORS
This study was conducted with approval from Institutional Review Board (IRB) (or its equivalent) of all the
institutions associated with this study. Authors take responsibility to maintain relevant documentation in this
respect.
LIST OF ABBREVIATIONS (In alphabetic order)
ACC - Atrophic cellular Changes
ACC - Atrophic Cellular Changes
AGC - Atypical Glandular Cells
HPV - Human Papillomavirus
IRB - Institutional Review Board
LBC - Liquid Based Cytology
LSIL - Low-Grade Squamous Intraepithelial Lesion




To ensure the integrity and highest quality of CytoJournal publications, the review process of this
manuscript was conducted under a double-blind model (authors are blinded for reviewers and vice versa)
through automatic online system.
ACKNOWLEDGMENT
We thank Michael Carroll CT (ASCP), Andrea Black CT (ASCP), Dongping Shi, MD, Erica Brandt, BS
(Student); and Karen Jones (Lab Assistant) for their support during the course of study. Kathleen Rost
(Executive Secretary) for the secretarial support. We appreciate Daniel Neill, MD for his editorial help and
support. This study was supported by limited funding from Hologic, Inc. Bedford, MA.
Footnotes
Available FREE in open access from: http://www.cytojournal.com/text.asp?2015/12/1/21/165955
Etiologic factors related to unsatisfactory ThinPrep® cervical cytology: Evaluation and potential solutions to improve
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4593297/?report=printable[10/7/2016 9:46:37 AM]
REFERENCES
1. Kalinicheva T, Nazeer N, King L, Giorgadze T, Bandyopadhyay S, Madan S, et al. Frequency and
etiology of unsatisfactory cervical cytology by ThinPrep method in a tertiary care urban setting – A
snapshot of brief duration. Mod Pathol. 2012;25(Suppl 1):93A. [Abstract 382]
2. Kalinicheva T, Masineni S, Zulfiqar M, Guan H, Bandyopadhyay S, Tranchida P, et al. Lubricant-related
high unsatisfactory rate with ThinPrep-can the cellularity be improved. Mod Pathol. 2013;26(Suppl 2):94A.
[Abstract 387]
3. Kalinicheva T, Nazeer N, Giorgadze T, Bandyopadhyay S, Madan S, Tranchida1 P, et al. Evaluation and
resolution of etiologic factors for unsatisfactory cervical cytology ThinPrep preparations. J Am Soc
Cytopathol. 2012;1(1 Suppl):S1–126. [Abstract #225]
4. Moriarty AT, Clayton AC, Zaleski S, Henry MR, Schwartz MR, Eversole GM, et al. Unsatisfactory
reporting rates: 2006 practices of participants in the college of American pathologists interlaboratory
comparison program in gynecologic cytology. Arch Pathol Lab Med. 2009;133:1912–6.
[PubMed: 19961244]
5. Fontaine D, Narine N, Naugler C. Unsatisfactory rates vary between cervical cytology samples prepared
using ThinPrep and SurePath platforms: A review and meta-analysis. BMJ Open. 2012;2:e000847.
[PMCID: PMC3332241]
6. Rosa M, Pragasam P, Saremian J, Aoalin A, Graf W, Mohammadi A. The unsatisfactory ThinPrep® Pap
Test™: Analysis of technical aspects, most common causes, and recommendations for improvement. Diagn
Cytopathol. 2013;41:588–94. [PubMed: 22833404]
7. NCI Bethesda System. Unsatisfactory for Evaluation. [Last accessed on 2015 Feb 09]. Available from:
http://nih.techriver.net/listing.php?tableOutline=2-2 .
8. Video: Shidham VB, Kalinicheva T, Frisch N, Nathan R, Shidham A. Protocol to Overcome Lubricant-
Like Debris (Shidham) – Higher Resolution FREE on YouTube. [Last accessed on 2015 Feb 09]. Available
from: https://www.youtube.com/watch?v=nFvqz9BGfXc .
9. How to Convert Centrifuge RPM to RCF or G-force? G-force=0.00001118xRxRPM . Clinfield Limited.
[Last accessed on 2015 Feb 09]. Available from: http://clinfield.com/2012/07/how-to-convert-centrifuge-
rpm-to-rcf-or-g-force/
10. Cervical Cancer Screening (PDQ®); Description of the Evidence – Background: Natural History,
Incidence, and Mortality. National Cancer Institute at National Institute of Health. [Last accessed on 2015
Feb 09]. Available from:
http://www.cancer.gov/cancertopics/pdq/screening/cervical/HealthProfessional/page2#Section_207 .
11. ASC Statement on New Technologies in Cervical Cytology Screening. American Society of
Cytopathology. [Last accessed on 2015 Feb 09]. Available from: http://www.cytopathology.org/new-
technologies/
12. Nayar R, Solomon D. Second edition of ‘The Bethesda System for reporting cervical cytology’ – Atlas,
website, and Bethesda interobserver reproducibility project. Cytojournal. 2004;1:4. [PMCID: PMC526759]
2
Etiologic factors related to unsatisfactory ThinPrep® cervical cytology: Evaluation and potential solutions to improve
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4593297/?report=printable[10/7/2016 9:46:37 AM]
[PubMed: 15504231]
13. NCI Bethesda System-2001 Bethesda System Terminology. [Last accessed on 2015 Feb 09]. Available
from: http://nih.techriver.net/bethesdaTable.php .
14. Chivukula M, Shidham VB. ASC-H in Pap test – Definitive categorization of cytomorphological
spectrum. Cytojournal. 2006;3:14. [PMCID: PMC1524979] [PubMed: 16686950]
15. Shidham VB, Kumar N, Narayan R, Brotzman GL. Should LSIL with ASC-H (LSIL-H) in cervical
smears be an independent category?. A study on SurePath specimens with review of literature. Cytojournal.
2007;4:7. [PMCID: PMC1851019] [PubMed: 17374161]
16. Stoler MH, Schiffman M. Atypical Squamous Cells of Undetermined Significance-Low-grade
Squamous Intraepithelial Lesion Triage Study (ALTS) Group. Interobserver reproducibility of cervical
cytologic and histologic interpretations: Realistic estimates from the ASCUS-LSIL Triage Study. JAMA.
2001;285:1500–5. [PubMed: 11255427]
17. Shidham VB, Mehrotra R, Varsegi G, D’Amore KL, Hunt B, Narayan R. p16 immunocytochemistry on
cell blocks as an adjunct to cervical cytology: Potential reflex testing on specially prepared cell blocks from
residual liquid-based cytology specimens. Cytojournal. 2011;8:1. [PMCID: PMC3045765]
[PubMed: 21369522]
18. ThinPrep, Hologic, In. [Last accessed on 2015 Feb 09]. Available from:
http://www.hologic.com/en/product-support/diagnostic-cytology/thinprep-2000/
19. The BD SurePath™ Liquid-based Pap test. [Last accessed on 2015 Feb 09]. Available from:
http://www.bd.com/tripath/physicians/surepath.asp .
20. Holton T, Smith D, Terry M, Madgwick A, Levine T. The effect of lubricant contamination on ThinPrep
(Cytyc) cervical cytology liquid-based preparations. Cytopathology. 2008;19:236–43. [PubMed: 18093222]
21. Evantash E. Bedford, MA: Hologic Inc; 2009. Lubricant use during Pap test collection.
22. Amies AM, Miller L, Lee SK, Koutsky L. The effect of vaginal speculum lubrication on the rate of
unsatisfactory cervical cytology diagnosis. Obstet Gynecol. 2002;100:889–92. [PubMed: 12423848]
23. Casselman CW, Crutcher RA, Jadusingh IH. Use of water-soluble gel in obtaining the cervical cytologic
smear. Acta Cytol. 1997;41:1861–2. [PubMed: 9390161]
24. Lin SN, Taylor J, Alperstein S, Hoda R, Holcomb K. Does speculum lubricant affect liquid-based
Papanicolaou test adequacy? Cancer Cytopathol. 2014;122:221–6. [PubMed: 24254917]
25. Feit TD, Mowry DA. Interference potential of personal lubricants and vaginal medications on ThinPrep
pap tests. J Am Board Fam Med. 2011;24:181–6. [PubMed: 21383218]
26. Haack LA, O’Brien D, Selvaggi SM. Protocol for the processing of bloody cervical specimens: Glacial
acetic acid and the ThinPrep Pap Test. Diagn Cytopathol. 2006;34:210–3. [PubMed: 16470866]
Figures and Tables
Figure 1
Etiologic factors related to unsatisfactory ThinPrep® cervical cytology: Evaluation and potential solutions to improve
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4593297/?report=printable[10/7/2016 9:46:37 AM]
ThinPrep  specimen distribution
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Common etiologic factors for unsatisfactory ThinPrep
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Wash protocol for preparation of repeat ThinPrep slide to improve cellularity (see also video at:
https://www.youtube.com/watch?v = nFvqz9BGfXc)
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Causes associated with unsatisfactory interpretations
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Morphologic subtypes of the LUBE associated with unsatisfactory TP
Figure 4
Improved cellularity with reduction in LUBE (dendritic-fluffy) in ThinPrep after (c and d) “wash protocol” as compared to
the cellularity before “wash protocol” (a and b)
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Cellularity results on repeat ThinPrep after “wash protocol”
Figure 6
Pattern of improvement in the cellularity of repeat ThinPrep for 256 specimens (out of 531) after wash protocol with
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reference to the final satisfactory status per Bethesda 2001 criteria
Table 3
Comparison of result related to interpretation patterns in the study group (after protocol wash) with general
population during same time period
Table 4
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